Literature DB >> 2172748

Enzyme immunoassays for leukotrienes C4 and E4 using acetylcholinesterase.

P Pradelles, C Antoine, J P Lellouche, J Maclouf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2172748     DOI： 10.1016/0076-6879(90)87012-r

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  6 in total

1.  Production of leukotrienes in a model of focal cerebral ischaemia in the rat.

Authors:  P Ciceri; M Rabuffetti; A Monopoli; S Nicosia
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

2.  Inhibition by troglitazone of the antigen-induced production of leukotrienes in immunoglobulin E-sensitized RBL-2H3 cells.

Authors:  M Yamashita; M Kushihara; N Hirasawa; W Takasaki; H Takahagi; M Takayanagi; K Ohuchi
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

3.  Toward antibody-catalyzed hydrolysis of organophosphorus poisons.

Authors:  P Vayron; P Y Renard; F Taran; C Créminon; Y Frobert; J Grassi; C Mioskowski
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

4.  Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis.

Authors:  Alexandra I Medeiros; Anderson Sá-Nunes; Edson G Soares; Camila M Peres; Célio L Silva; Lúcia H Faccioli
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

5.  Effects of compounds extracted from Santolina oblongifolia on TXB(2) release in human platelets.

Authors:  A M Silván; M J Abad; P Bermejo; A Villar
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

6.  Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid.

Authors:  P Bertin; F Lapicque; E Payan; M Rigaud; F Bailleul; S Jaeger; R Treves; P Netter
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.